跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Tirifex - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Tirifex
Approved
STANDARD
Tirifex
Brawn Laboratories Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
220f4e988bd17cd6
Company
Brawn Laboratories Ltd.
Type
Standard
Approval Details
Approval Id
220f4e988bd17cd6
Drug Approval Philippines Name
Tirifex
Product Name
Tirifex
Registration Number
DRP-4474-11
Brand Name
Tirifex
Generic Name
Ceftriaxone (As Sodium)
Dosage Form
Powder For Injection (I.M./I.V.)
Dosage Strength
1 g
Manufacturer
Brawn Laboratories Ltd.
Importer
Ambica International Corporation
Distributor
Crismeed Pharmaceutical Trading
Issuance Date
26 October 2022
Expiry Date
13 June 2028
Pharmacologic Category
Antibacterial (Cephalosporin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
220f4e988bd17cd6
Type
Standard
Back to Philippines FDA Approvals